Zentek Ltd.(ZTEK)Earnings, Financials & Key Ratios
ZTEK•NASDAQ
$0.39
Price updated Jun 25, 2026
AboutZentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.Show more
- Revenue$872K+2826.3%
- EBITDA-$9M+20.8%
- Net Income-$10M+14.2%
- EPS (Diluted)-0.10+16.7%
- Gross Margin22.06%+102.2%
- EBITDA Margin-1031.56%+97.3%
- Operating Margin-1100.37%+97.3%
- Net Margin-1150.68%+97.1%
- ROE-67.74%-31.0%
ZTEK Price & Volume
Zentek Ltd. (ZTEK) stock price & volume — 10-year historical chart
Loading chart...
Persistent Cash Burn Challenges Zentek Commercial Scaling
Investment Thesis • Updated 2025Q4
VerdictNegative
Growth:Mixed
Profitability:Negative
Financial Position:Vulnerable
Cash Flow:Burning
Primary Risk:Acute liquidity and dilution
"Zentek faces a precarious financial outlook characterized by erratic revenue generation and a failure to establish a sustainable commercial sales cycle for its graphene-based products. While the company holds proprietary intellectual property, the persistent operating losses, which reached $3.9 million in 2025Q4, suggest that the firm remains heavily reliant on external financing. Investors should monitor the company's ability to manage its $1.3 million cash balance against ongoing operational deficits, as the current trajectory points toward continued shareholder dilution."
Verdict Logic
the company's reliance on equity financing to cover operating losses, combined with a dwindling cash reserve of only $1.3 million, presents an acute risk of further dilution for existing shareholders.
ZTEK Growth Metrics
Zentek Ltd. (ZTEK) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years36.95%
TTM1358.21%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM24.19%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM29.8%
Return on Capital
10 Years-27.27%
5 Years-43.44%
3 Years-53.48%
Last Year-63.49%
Peers Comparison
Key metrics vs top competitors for Zentek Ltd. (ZTEK)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.39 | $41.94M | -5.55 | 2826.26% | -1150.68% | -67.74% | — | |
| $11.05 | $7.23M | -0.33 | — | — | -66.39% | — | |
| $0.88 | $61.2M | -0.76 | 15.4% | -576.13% | -47.09% | — | |
| $8.36 | $79.35M | 4644.44 | -0.97% | -0.87% | -1.01% | — | |
| $0.32 | $37.74M | -20.46 | 2.68% | -10.76% | -77.48% | — | |
| $9.43 | $106.38M | 25.49 | 30.75% | 17.66% | 8.33% | — |
Compare ZTEK vs Peers
Zentek Ltd. (ZTEK) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when ZTEK posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ZTEK Frequently Asked Questions
Zentek Ltd. (ZTEK) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Zentek Ltd.'s revenue?
Zentek Ltd. (ZTEK) reported $0.9M in revenue for fiscal year 2024.
How fast is Zentek Ltd. growing?
Zentek Ltd. (ZTEK) grew revenue by 2826.3% over the past year. This is strong growth.
Is ZTEK profitable?
Zentek Ltd. (ZTEK) reported a net loss of $8.1M for fiscal year 2024.
Dividend & Returns
What is ZTEK's return on equity?
Zentek Ltd. (ZTEK) has a return on equity (ROE) of -67.7%. Negative ROE indicates the company is unprofitable.
What is Zentek Ltd.'s free cash flow?
Zentek Ltd. (ZTEK) had negative free cash flow of $6.0M in fiscal year 2024, likely due to heavy capital investments.